Economic-Life Books
Related Subjects:
More Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250

Used price: $0.83
Collectible price: $24.95

Compelling tale about greed and how the system worksReview Date: 2004-04-19
A GRIPPING YARN!!!!Review Date: 2004-01-28
The Waksal-Stewart ConnectionReview Date: 2004-01-27
Reads like a novel, but it's a true storyReview Date: 2004-02-22
Sam Waksal, a scientist and business developer with a checkered past, lives a celebrity lifestyle, hanging out with the rich and famous, owning several fancy houses, driving fast cars, and heading a firm that is working on a cancer drug so promising that people with no other hope of treatment are flinging themselves at ImClone, begging for a merciful dose of "Erbitux."
The drug apparently does reverse inoperable tumors in a few test patients who had no other hope of living. Now the race is on to fast-track the drug through the FDA approval process based on the glowing clinical trials. But the FDA reviewer is unaccountably unencouraging when meeting with one of ImClone's top scientists. What is wrong? Is Erbitux, instead of being approved , instead going have its application refused? Why! And what will this mean for the high-flying ImClone stock?
The book reads like the best thriller, and author Alex Prud'homme is adept at making you feel like the proverbial fly-on-the-wall during the action. If you are at all interested in what happened behind the Martha Stewart debacle, you must read this. It's fantastic.
Lively character study about Sam Waksal - needless tragedyReview Date: 2004-02-14
It is amazingly sad that all of this misery was so pointless because Erbitux has at last been approved. It almost certainly could have been approved earlier if the talented team at ImClone would have had a culture of discipline and getting things done and documented in ways that everyone knew the FDA required. If they had, all this pain and loss would never have occurred and Dr. Waksal would be a real hero instead of the one he only pretended to be.
Mr. Prud'homme writes with style and vitality. The book moves along well and has a great feel for keeping the story personal and emotionally accessible for the reader. We don't get overwhelmed with the scientific side of things, although it is always interesting to read about this emerging science and the wizards who are making it happen.

Used price: $0.21
Collectible price: $101.01

Use CEO Road Rules as a road manual for implementing values-based business planning.Review Date: 2006-12-11
Diane C. Donovan
California Bookwatch
Business OwnerReview Date: 2006-12-06
CEO PsychologyReview Date: 2006-11-23
Fast track to effective leadershipReview Date: 2006-11-01
Key and Stearns offer specifics on how to find the right people, gain the right focus and accomplish the right execution, as well as for how to leave the right legacy - an essential aspect of the process. This book contains a wealth of practical information that is clearly presented and can be readily applied.
CEO Road Rules is both a compelling story and a valuable guide book for achieving success in business and - perhaps most importantly - in life.
Rules to live by across the board....Review Date: 2006-10-18
This book is a must for CEOs, entrepreneurs, upper management, or anyone interested in building a lasting legacy. You will come away invigorated and with new appreciation for those who work alongside you.

Used price: $9.99

Truly a Classic...Review Date: 2008-09-17
This book will need to sit on your bookshelf. It's a nice compilation of work Drucker has written over his many years. I've got this on my re-read list so basically every once in a while when I need business inspiration I walk over to the shelf and go through his sage advice.
Simplicity on the other side of complexityReview Date: 2006-06-19
To me, one of Peter Drucker's greatest strengths as a business thinker is his ability to cut to the proverbial "bone" when sharing an insight about an especially complicated subject. This unique talent illustrates what Oliver Wendell Holmes meant when observing that he didn't "care a fig about simplicity on this side of complexity" but greatly admired simplicity "on the other side of complexity." Given Holmes' observation, consider these three prime examples of "classic Drucker":
In 1963: "There is surely nothing quite so useless as doing with great efficiency what should not be done at all." (Managing for Business Effectiveness, page 83)
In 1995: "EVA [economic value added] is based on something we have known for a long time: what we generally call profits, the money left to service equity, is usually not profit at all. Until a business returns a profit that is greater than its cost of capital, it operates at a loss...By measuring the value added among all costs, including the cost of capital, EVA measures, in effect, the productivity of all factors of production." (The Information Executives Truly Need, page 107)
In 1988: "Information-based organizations, in other words, require clear, simple, common objectives that translate into particular actions. At the same time, however, as these examples dicate, information-based organizations also need concentration on one objective or, at most, on a few. Because the `players' in an information-based organization are specialists, they cannot be told how to do their work...So [such an organization] must be structured around goals that clearly state management's performance expectations for the enterprise and for each part and specialist and around organized feedback that compares [and contrasts] results with these performance expectations so that every member can exercise self-control. The other requirement of an information-based organization is that everyone takes information responsibility...The key to such a system is that everyone asks: Who in this organization depends on me for what organization? And on whom, in turn, do I depend?" (The Coming of the New Organization, page 133)
There several other excellent sources of Drucker quotations (e.g. The Daily Drucker) which I frequently consult. However, in the 15 Harvard Business Review articles which are assembled in Classic Drucker, there is a context within which the value of each insight is more clearly indicated. In the Introduction, Thomas A. Stewart (editor of the Harvard Business Review) cites three of Drucker's great gifts to his life work: "First was the talent for asking the right questions...His second gift was to see organizations whole...[Drucker's] third gift was the ability to reason equally well both inductively and deductively." All three gifts are clearly evident in each of the 15 articles.
Near the conclusion of an interview by T. George Harris in 1993, Drucker makes several points which seem even more relevant now: "'Democratic' bespeaks a narrow and legal organization. Nor do I use the buzzword `participative.' Worse yet is the `empowerment' concept. It is not a great step forward to take power out at the top and put it in at the bottom. It's still power. To build achieving organizations, you must replace power with responsibility."
During the months and years to come, decision-makers in all organizations (regardless of nature or size) would be well-advised to keep such basic business precepts in mind, not as simplistic solutions to immensely complicated problems but, rather, as fundamentally sound principles to keep in mind when attempting to solve such problems.
Great management bookReview Date: 2007-09-24
A compendium of business wisdom which should be in every business library collectionReview Date: 2006-07-04
Wisdom for the agesReview Date: 2007-01-05

Used price: $10.91

For the history buff; genealogy researcher in this era; student, & the person who loves detailed pencil or pen & ink drawingsReview Date: 2008-07-17
A how-to-do-it book of Colonial tradesReview Date: 2008-02-23
An Exploration of Colonial Material CultureReview Date: 2008-02-17
Edwin Tunis was one of the great author/illustrators of young adult non-fiction. "Colonial Craftsmen" is brimming over with beautifully intricate pencil drawings. This is the type of fascinating book, in which a young person can lose themselves. Along the same lines, the other great author/illustrator of American material culture is Eric Sloane. Any book by these two prodigies will be loved by all those with an interest in American history and its material manefestations.
Insightful peek at pre-industrial AmericaReview Date: 2006-05-15
A must have for anyone interested in the period.
Classic history/reference bookReview Date: 2003-04-12


"One-Stop" Comp Reference BookReview Date: 2008-07-12
Mind you, there are more comprehensive treatments available for specialty or "single-topic" compensation areas, such as executive or sales compensation, but none that provide the overall breadth of The Compensation Handbook as resource guide on many key areas of compensation management.
Great ReferenceReview Date: 2007-04-24
The book is essential for compensation professionals.
The Compensation HandbookReview Date: 2006-02-25
The Compensation HandbookReview Date: 2000-06-27
The Compensation HandbookReview Date: 2000-06-26
Used price: $1.79
Collectible price: $135.55

cost of livingReview Date: 2008-05-23
Vision of the FutureReview Date: 2004-09-29
It's an enchanting but difficult read. Barry Schwartz, whose more recent Paradox of Choice garnered a New Yorker review and positive press for dealing with the same topics on the level of the individual, here demonstrates instead the powerlessness of the individual to stop the relentless advance of market forces into every domain of life. Moving from business to medicine to law to sports to love to education to democracy, Schawrtz shows how the things we purport to value most in life are now subject to market influence--and argues, persuasively, that they are far worse for it.
This is enchanting because Schwartz is a fantastic writer, good at using examples to make his points and capable of humor and serious concern in equal measure. The reading is made difficult by the fact that the book was written in 1994. Rather than the doomsday prophet that Schwartz surely seemed upon publication, he now appears oddly prescient about the continuing advances the market would make into all spheres of life if people did not band together to stop it. While he could not have anticipated the ways in which people's yearning for community in the face of these forces would be exploited by politicians willing to wield those communities' principles as marketable commodities--and how those politicians would use their resulting power to help the market forces advance ever faster--the ingredients of that recipe for disaster are all quite plain to the reader with benefit of knowledge of the ensuing decade.
Can we still turn things around? The task is undoubtedly even more difficult now than Schwartz suggested it would be ten years ago. But we ought to try, and Costs of Living still offers a good way to start constructing the framework by which we might begin to do so. Highly recommended.
Thoughtful, Provocative, and ReadableReview Date: 2001-05-11
This is a marvelous book that explores how people should think about their places in our society. Schwartz, a Professor at Swarthmore College, has a well-deserved reputation for debunking commonly held myths promulgated by economists and others who seek to explain all human behavior by supply and demand curves, and irresistible biological imperatives.
Yes, we do have a choice about how we want our communities to function, and Schwartz tells us how we can ``reintroduce the language of responsibility and morality into our public life.''
Schwartz also has a rare gift for making complex topics seem easy to understand. This is a surprisingly readable book, full of anecdotes and examples that will help you relate the ideas to your own life. Its conclusion, about a dilemma Schwartz faced in his own community, is notable for its drama as well as for the fact that Schwartz declines to offer easy answers.
Read this book, and you will think differently (and more perceptively) about the world around you. It is *that* good.
A good description of the choices of middle class life.Review Date: 1999-06-27
A fantastic and important bookReview Date: 1999-02-19

Collectible price: $16.95

A book to get you off the couchReview Date: 2008-01-18
Nice solutions!Review Date: 2002-11-05
Helen's breezy, upbeat style makes for an uplifting read, which can be helpful to clients who are feeling overwhelmed by their stuff.
FocusReview Date: 2002-10-30
Offers more than just helpful adviceReview Date: 2002-10-29
Helen Volk's book offers the reader more
than just helpful advice. Her book serves as a partner and coaches you through the de-cluttering process. She uses humor,
support and practical
guidance in order to help you to make progress in your de-cluttering efforts. If you're unable to
attend her wonderful groups and workshops you can certainly benefit from this book and gain some valuable tools that are culled
from her expertise and personal experience. I highly recommend this book to anyone who wants to learn how to let go of "stuff"
that no longer serves you and experience greater peace of mind and a more organized physical environment.
Debra Gugig-Bauer,
CRC, CASAC
President,
CATALYSTS FOR CHANGE
COUNSELING AND TRAINING ASSOCIATES
De-Clutter, De-stress Your LifeReview Date: 2002-10-28


In-depth Analysis of Race RelationsReview Date: 2001-08-07
Much Needed TheoryReview Date: 2000-10-25
Much Needed TheoryReview Date: 2000-10-25
Superb - Balanced Treatment of the TopicReview Date: 2000-10-05
Broadens the Area of ResearchReview Date: 2000-09-30

Used price: $3.25

Unprecedented piece of work on life, liberty, and leadershipReview Date: 2003-02-05
A rare moment of enlightenment!Review Date: 2003-10-16
It's about time!Review Date: 2003-05-27
Ground-breaking and thought-provokingReview Date: 2003-05-08
Ground-breaking and thought-provokingReview Date: 2003-05-06

Collectible price: $21.75

The hidden truth about Earl Nightingale's success in life.Review Date: 2005-09-20
Earl nightingale has an astounding mind and with it he has created some of the best literature and audio books I have ever obtained.
This particular book gives insight and understanding to the idea of success for anyone. Living succesfully is not some unicorn idea that only a few can have, its rather the state of mind that makes successful individuals.
The arguments Earl Nightingale proves wrong are some of todays most common held beliefs about wealth, determination, and spirit. They are unarguable the truth from a man whos known poverty as though it were his best friend.
THE MASTER OF SUCCESS AND MOTIVATION!!Review Date: 1999-04-17
A must have bookReview Date: 2005-08-07
Reviews?Review Date: 2006-03-12
Greatest DiscoveryReview Date: 2006-02-25
Related Subjects:
More Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250
It is specifically about the rise and fall of one Sam Waksal, oldest son of Jewish emigrants and Holocaust survivors, a man of irresistible charm, fabulous energy, and great intelligence, a man driven to success and the high life, a man who had bounced around academia without much success until in the 1980s he saw an opportunity to become a player in the cancer game, and, along with his younger brother Harlan, founded ImClone Systems, Inc.
It is also about an anticancer drug called Erbitux, originally known as C225 because it was the 225th drug tested by its discoverers, John Mendelsohn and Gordon Sato in 1980. It showed promise because in tests it stopped the growth of tumors in mice.
And finally it is a story about how drugs get discovered, how they are developed, and especially how they get approved (or not) by the Food and Drug Administration. And of course it is about the Byzantine and incestuous relationship that exists between that August government agency and the massive pharmaceutical industry.
The curious thing about all this is that Imclone never turned a profit, Erbitux never came to market, and most of the people associated with Waksal and ImClone either made out like bandits or got stuck holding the bag. The drug itself, which works against cancer tumors, particularly colon cancer, by cutting off the blood supply to the tumors (an "antiangiogenesis" drug), was touted as a miracle that would save the lives of innumerable patients and make possibly billions of dollars for ImClone.
At least this was the hype delivered by Sam Waksal, and bought hook, line and sinker by pharma giant Bristol-Myers Squibb, and by desperate cancer patients as well as salivating Wall Street investors who jumped on the bandwagon as ImClone's stock rocketed skyward. Because of the promise of the drug, Waksal himself was able to live his dream life as a New York socialite, throwing lavish parties for celebs (including Martha Stewart while he dated her daughter), collecting fine art, popping open $600 bottles of Chateau Lafite-Rothschild while secretly selling stock on the side, sending the proceeds overseas, buying expensive apartments and houses for himself, etc., etc.
But the cold hard facts of Erbitux, like those of almost any cancer drug one can name, are very far from the hype. As Prud'homme notes on pages 332-333, "these agents...[Erbitux and others like Avastin and Iressa] are remarkable scientific advances, [but] they still only benefit some 10 to 20 percent of patients, and they only extend patients' lives by a matter of months."
That's it. That's the bottom line. And yet these drugs are so valuable that the companies that end up selling them can make hundreds of millions if not billions of dollars.
Waksal apparently came to this understanding sometime during the early eighties. He realized first the simple fact that the way the cancer industry works is doctors have to prescribe something rather than nothing. Then he realized that living a few months longer can mean a lot to people. Therefore any FDA-approved cancer drug will automatically fill a need. What this means is that the PROMISE of a cancer drug, if cleverly promoted, will spark a rally in the shares of the company that owns the patent. If, like Sam Waksal, you own millions of those shares, you can get rich on mere promise alone.
Furthermore, should the drug have any real value at all, and be approved (or even look like it's going to be approved) by the FDA, you might be able to get some pharmaceutical giant like Bristol-Myers Squibb to front a whole lot of money on that promise since they are desperate to find a cancer drug to replace those that have gone generic.
This works because even drugs with very limited effectiveness are better than no drug at all. This is true for many patients, for many doctors, and is especially true for the big pharmaceutical companies.
Note that these drugs are valuable because the people who need them are typically people of relative means who can afford to pay large sums of money for them, either through their HMOs, their government, or their own funds. In contrast a drug that would prolong the life of poor people in third world countries would be of only marginal value to the big pharmaceutical companies.
I should also mention that Prud'homme spends some serious ink in this book on Waksal's long-time friend Martha Stewart and her troubles. Her personality, her empire, and the way she handles herself are vividly detailed. In fact, some readers might find her story the most interesting part of the book.